Atossa Therapeutics
ATOS
#8061
Rank
A$0.28 B
Marketcap
$2.30
Share price
-7.41%
Change (1 day)
132.25%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2024 (TTM): -A$42.6 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -A$41.32 Million a decrease over its 2021 earnings that were of -A$31.59 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$42.6 Million
2022 -A$41.32 Million30.84%
2021 -A$31.59 Million15.58%
2020 -A$27.33 Million3.41%
2019 -A$26.43 Million51.16%
2018 -A$17.48 Million40.41%
2017 -A$12.45 Million27.54%
2016 -A$9.77 Million-47.49%
2015 -A$18.59 Million-17.25%
2014 -A$22.47 Million35.91%
2013 -A$16.53 Million112.3%
2012 -A$7.79 Million46.53%
2011 -A$5.32 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$28.19 B-65,829.29%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.26 B-3,038.25%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.70 B-4,076.99%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$15.05 Million-64.92%๐Ÿ‡บ๐Ÿ‡ธ USA
A$63.88 M-248.94%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.12 Billion 172.74%๐Ÿ‡บ๐Ÿ‡ธ USA